Home › Small Cell Lung Cancer › District of Columbia › Washington
Pag-aaral pangklinika para sa Small Cell Lung Cancer sa Washington, DC
Isang pag-aaral para sa Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Washington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
Nagre-recruitPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Nagre-recruitPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
- Georgetown University Medical Center, Washington D.C.
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Site 1001, Washington D.C.
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Nagre-recruitPhase 3
- Maryland Oncology Hematology, Silver Spring · 7 mi ang layo
- American Oncology Partners, PA - The Center for Cancer and Blood Disorders, Bethesda · 7 mi ang layo
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Nagre-recruitPhase 2
- Georgetown Lombardi Cancer Center, Washington D.C.
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Nagre-recruitPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- National Institutes of Health, Bethesda · 7 mi ang layo
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Nagre-recruitPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Nagre-recruitPhase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
Pag-aaral para sa Small Cell Lung Cancer sa ibang lungsod
- Houston, TX26 pag-aaral
- Arlington, VA23 pag-aaral
- New York City, NY22 pag-aaral
- Boston, MA21 pag-aaral
- Nashville, TN20 pag-aaral
- Los Angeles, CA20 pag-aaral
- Orlando, FL15 pag-aaral
- Dallas, TX13 pag-aaral
- Cleveland, OH13 pag-aaral
- Chicago, IL13 pag-aaral
- St. Louis, MO13 pag-aaral
- Detroit, MI12 pag-aaral
Iba pang pag-aaral sa Washington
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer55 pag-aaral
- Kanser sa Suso46 pag-aaral
- Metastatic Cancer43 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser sa Prostate38 pag-aaral
- Obesity33 pag-aaral
- Colorectal Cancer29 pag-aaral
- Sakit sa Puso at Ugat ng Dugo28 pag-aaral
- Kanser sa Pantog26 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Kanser sa Ovary23 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.